Menu
X

2024 AACR | China’s Innovative Medicine Leads Globally! Dazzling International with Multi-Cancer Research Achievements

πŸ”¬βœ¨ 2024 AACR | China’s Innovative Medicine Leads Globally! Dazzling International with Multi-Cancer Research Achievements

AACR2024

AACR2024

#AACR

🎏This month, the annual cancer research summit, #AACR, arrived in San Diego, USA! Focused on #tumor research and innovation, top global achievements were fully showcased. Under China’s Biopharmaceuticals, the new drug, Anlotinib from Zhongda Tianqing, shines brightly!

πŸ” Latest Research Progress

ALTER-G-001, a diversified and cross-regional Phase II study, unveiled the latest results of Cohort C. Patients receiving Anlotinib + standard chemotherapy for 6 cycles showed remarkable efficacy. Anlotinib combined with chemotherapy, especially demonstrated significant effects in pancreatic cancer patients!

πŸ“Š Key Data

Enrolled 41 patients, covering various cancer types including pancreatic, #gastric, #biliarytract, and #duodenal cancer,

ORR reached 42.3% in #pancreaticcancer patients

DCR soared to 88.5%

Median PFS reached 5.8 months

After efficacy assessment, tumors in 14 SD patients showed shrinkage

🌟 Treatment Outlook

Research results indicate that Anlotinib combined with chemotherapy as first-line treatment, particularly for digestive tract tumors with unresectable liver metastases, especially in pancreatic cancer patients, has significant efficacy. This may open up a completely new treatment path for such patients, bringing new hope!

✨ Embark on an exploration of life from here!

πŸŽ‰πŸŽ‰To assess whether the condition is suitable for CAR-T or clinic therapy, you can submit Advanced Medicine in China for preliminary evaluation!

WhatsApp: +8613717959070

Email: doctor.huang@globecancer.com

By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.

Β© Copyright 2023 Advanced Medicine In China. All rights reserved.